Drugs / QBI-139
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00818831 | Jan 2009 → Oct 2015 | cancer | Quintessence Biosciences, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QBI-139 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00818831 ↗ |
| Route | Intravenous | “IV infusion” NCT00818831 ↗ |